References

Bloomgarden, Z.T., 2008. Approaches to treatment of pre-diabetes and obesity and promising new approaches to type 2 diabetes. Diabetes Care, 31: 1461-1466.
Direct Link  |  

Dolphin, P.J., B. Stewart, R.M. Amy and J.C. Russell, 1987. Serum lipids and lipoproteins in the atherosclerosis prone LA/N-corpulent rat. Biochim. Biophys. Acta., 919: 140-148.
PubMed  |  

Hennes, M.M., S. MuCune, E. Shargo and A.H. Kissebah, 1988. Effects of obesity and male gender on hepatic insulin dynamics: Studies in the SHR/N corpulent rat. Clin. Res., 36: 483-483.

Kawano, K., T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi and T. Natori, 1992. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes, 41: 1422-1428.
PubMed  |  

Kendall, D.M. and R.M. Bergenstal, 2001. Comprehensive management of patients with type 2 diabetes: Establishing priorities of care. Am. J. Manag. Care, 7: S327-S343.
PubMed  |  

Kimura, K., T. Toyota, M. Kakizaki, M. Kudo, K. Takebe and Y. Goto, 1982. Impaired insulin secretion in the spontaneous diabetes rats. Tohoku. J. Exp. Med., 137: 453-459.
PubMed  |  

Kosaka, K., 2002. Pathogenesis of type 2 diabetes mellitus from the viewpoint of clinical epidemiology. Nippon Rinsho, 7: 423-467.
PubMed  |  

Kosaka, K., R. Hagura and T. Kuzuya, 1977. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes, 26: 944-952.
PubMed  |  

Kubota, N., K. Tobe, Y. Terauchi, K. Eto and T. Yamauchi et al., 2000. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes, 49: 1880-1889.
PubMed  |  

Masuyama, T., K. Komeda, A. Hara, M. Noda and M. Shinohara et al., 2004. Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. Biochem. Biophys. Res. Commun., 314: 870-877.
CrossRef  |  

Matsui, K., T. Oda, E. Nishizawa, R. Sano and H. Yamamoto, et al., 2009. Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage. Exp. Anim., 58: 363-374.
CrossRef  |  PubMed  |  Direct Link  |  

Michaelis, O.E., H. Carswell, C.T. Hansen, J.J. Canary and P. Kimmel, 1988. A New Genetic Model of Non-Insulin Dependent Diabetes Mellitus (Type II) and Hypertension: The Spontaneous Hypertensive/NIH-Corpulent Rat. In: Frontiers in Diabetes Research. Lessons from Animal Diabetes II, Shafrir, E. and A.E. Renold (Eds.). John Libbey, London, pp: 257-264.

Ohta, T., K. Matsui, K. Miyajima, T. Sasase, T. Masuyama et al., 2007. Effect of insulin therapy on renal changes in Spontaneously Diabetic Torii rats. Exp. Anim., 56: 355-362.
PubMed  |  

Ohta, T., K. Miyajima and T. Yamada, 2010. Pancreatic weakness in Zucker Fatty rats, a genetic obese model. J. Anim. Vet. Adv., 9: 2963-2968.
Direct Link  |  

Ohta, T., K. Miyajima, G. Komuro, N. Furukawa and F. Yonemori, 2003. Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent in diabetic Goto-Kakizaki rats. Eur. J. Pharmacol., 476: 159-166.
PubMed  |  

Sasase, T., T. Ohta, N. Ogawa, K. Miyajima and M. Ito et al., 2006. Preventive effects of glycaemic control on ocular complications of spontaneously diabetic torii rats. Diabetes Obes. Metab., 8: 501-507.
PubMed  |  

Shibata, T., K. Matsui, F. Yonemori and K. Wakitani, 1998. JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models. Br. J. Pharmacol., 125: 1744-1750.
CrossRef  |  

Shinohara, M., T. Masuyama, T. Shoda, T. Takahashi and Y. Katsuda et al., 2000. A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int. J. Exp. Diabetes Res., 1: 89-100.
PubMed  |  

Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res., 50: 537-546.
PubMed  |  Direct Link  |  

Terauchi, Y., I. Takamoto, N. Kubota, J. Matsui and R. Suzuki et al., 2007. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. J. Clin. Invest., 117: 246-257.
PubMed  |  

Tokuyama, Y., J. Sturis, A.M. DePaoli, J. Takeda and M. Stoffel et al., 1995. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes, 44: 1447-1457.
PubMed  |  

Unger, R.H. and S. Grundy, 1985. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes. Diabetologia, 28: 119-121.
CrossRef  |  

Unger, R.H., 1995. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes, 44: 863-870.
CrossRef  |